Bellevue Group AG 13F Holdings
CIK 0001674546 · ZURICH, V8
As of Sep 30, 2025, Bellevue Group AG reported 148 positions worth $4.8B in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 6,244,451 | $408.5M | 8.49% |
| ARGENX SE | ARGX | Healthcare | 546,328 | $402.9M | 8.37% |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 5,573,838 | $260.3M | 5.41% |
| NEUROCRINE BIOSCIENCES INC | NBIX | Healthcare | 1,763,105 | $247.5M | 5.14% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | Healthcare | 446,524 | $203.6M | 4.23% |
| VERTEX PHARMACEUTICALS INC | VRTX | Healthcare | 505,805 |